Watson Pharmaceuticals Receives FDA Approval for Testosterone Gel Product testosterone gel 1% CIII is the generic equivalent to Solvay Pharmaceutical's androgel(R), which is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Assuming that this product really is equivalent to Androgel, this seems like good news to me. When Solvay purchased the rights for Androgel from Unimed Pharmaceuticals Inc, they increased the cost by 400%. That potentially bad part to this is that it reduces the incentive for Solvay to fund new clinical studies for Androgel. However, I am well aware that Solvay is currently funding a clinical trial of Androgel for hypogonadal men with diabetes, so perhaps we are okay on that front. I look at testosterone cypionate, for which the package insert still says q2w-q4w, and I realize that the drug companies aren't actively promoting a drug that is available as a generic. One thing I wonder about is: what would the generic for Testim be called? The website for Testim also refers to Testim as Testosterone gel 1% CIII, but it obviously different since it received its own patent. It think that SWALE said that Testim has something else added to it, although I can't remember the word he used to describe what was added. It'll be interesting to see if pharmacies start filling prescriptions for 'Testim' with this new generic product. Technically, I believe that they shouldn't. But hey, pharmacies have filled prescriptions from Androgel with Testim, much to the dismay of Solvay which I assumed worked to stop that practice.